We would like to show you a description here but the site won’t allow us.

Jul 23, 2024 · Correction Open access Published: 23 July 2024 Correction: CRISPR/Cas-based CAR-T cells: production and application Ping Song, Qiqi Zhang, Zhiyong Xu, Yueli Shi, Ruirui Jing & …

Published: 10 June 2021 Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome Xin Huang, Cunte Chen, Mengjun Zhong, Suxia Geng, Yujie …

May 14, 2016 · Due to the exploratory nature of the study, our results should mainly be regarded as hypothesis-generating, providing a basis for further exploration of IFITM1 as a biomarker in …

May 30, 2014 · Review Open access Published: 30 May 2014 Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment Jahangir Abdi, Lugui Qiu & Hong Chang Biomarker …

Jun 6, 2013 · Review Open access Published: 06 June 2013 Molecular signatures of chronic myeloid leukemia stem cells Yaoyu Chen & Shaoguang Li Biomarker Research 1, Article number: 21 (2013) …

Correction: Biomarker Research (2024) 12:54 https://doi.org/10.1186/s40364-024-00602-z The authors wish to note Ruirui Jing as a co-Corre-sponding Author of the original article; the attribution of which …

Apr 21, 2017 · Review Open access Published: 21 April 2017 Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review John Ha, Aysha Chaudhri, Abhishek Avirineni …

The biomarker potential of a specific panel of methylated genes for ECa was confirmed. These might prove useful for early detection and might allow for the identification of minimal residual disease after …

May 21, 2018 · As a result, a number of miRNAs have shown great potential as prognostic biomarkers in PDAC. Hopefully these biomarker miRNAs will form a solid foundation to better manage clinical …